Home › Colorectal Cancer › California › Fullerton
Colorectal Cancer clinical trials in Fullerton, CA
3 studies for Colorectal Cancer are looking for participants at sites in and around Fullerton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecruitingPhase 3
- Providence Medical Foundation, Fullerton
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RecruitingPhase 2
- Providence Medical Foundation - Fullerton /ID# 274207, Fullerton
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
RecruitingPhase 1
- Saint Jude Medical Center / Providence Medical Foundation, Fullerton
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Fullerton
- Non-Small Cell Lung Cancer13 studies
- Breast Cancer9 studies
- Ovarian Cancer6 studies
- Lupus5 studies
- Cancer (all types)5 studies
- Lung Cancer4 studies
- Pancreatic Cancer4 studies
- Stomach Cancer3 studies
- Esophageal Cancer3 studies
- Melanoma3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Schizophrenia3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.